Antonio Ghidini

ASST Bergamo Ovest, BG
Treviglio, Italy

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 102 publications

Interstitial lung disease in patients treated with antibody-drug conjugates: a review.

Interstitial lung disease in patients treated with antibody-drug conjugates: a review.

Journal: Lung cancer (Amsterdam, Netherlands)

Published: June 24, 2026

Next-Generation Checkpoint Combinations: Optimizing PD-(L)1-Based Therapy Across the Advanced, Adjuvant, and Neoadjuvant Settings.

Next-Generation Checkpoint Combinations: Optimizing PD-(L)1-Based Therapy Across the Advanced, Adjuvant, and Neoadjuvant Settings.

Journal: Current oncology reports

Published: May 26, 2026

Psychological Stress and Cancer Risk and Outcome: An Umbrella Review With Quantitative Synthesis.

Psychological Stress and Cancer Risk and Outcome: An Umbrella Review With Quantitative Synthesis.

Journal: Asia-Pacific journal of clinical oncology

Published: May 06, 2026

A decade of progress in small-cell lung cancer (2015-2025): a narrative review.

A decade of progress in small-cell lung cancer (2015-2025): a narrative review.

Journal: European journal of clinical pharmacology

Published: April 21, 2026

Latitude, seasonality, and circadian determinants of outcomes of systemic cancer therapy: Evidence from chemotherapy, immunotherapy, and chemo-immunotherapy combinations. A systematic review.

Latitude, seasonality, and circadian determinants of outcomes of systemic cancer therapy: Evidence from chemotherapy, immunotherapy, and chemo-immunotherapy combinations. A systematic review.

Journal: Critical reviews in oncology/hematology

Published: April 02, 2026

Immune-Related Adverse Events From Checkpoint Inhibitors: An Evidence-Based Management Review.

Immune-Related Adverse Events From Checkpoint Inhibitors: An Evidence-Based Management Review.

Journal: Critical reviews in oncology/hematology

Published: February 25, 2026

Immune-related adverse events from checkpoint inhibitors: An evidence-based management review.

Immune-related adverse events from checkpoint inhibitors: An evidence-based management review.

Journal: Critical reviews in oncology/hematology

Published: February 25, 2026

Central nervous system and cancer: mechanistic insights and therapeutic opportunities CNS and cancer: a review.

Central nervous system and cancer: mechanistic insights and therapeutic opportunities CNS and cancer: a review.

Journal: Medical oncology (Northwood, London, England)

Published: January 18, 2026

The Role of Androgen Receptor and Antiandrogen Therapy in Breast Cancer: A Scoping Review.

The Role of Androgen Receptor and Antiandrogen Therapy in Breast Cancer: A Scoping Review.

Journal: Current oncology (Toronto, Ont.)

Published: December 02, 2025

Advanced cholangiocarcinoma in 2025: Therapeutic sequencing and global implementation.

Advanced cholangiocarcinoma in 2025: Therapeutic sequencing and global implementation.

Journal: Med (New York, N.Y.)

Published: September 19, 2025

Trastuzumab deruxtecan in non-breast solid tumors: Expanding indications, efficacy, and future directions.

Trastuzumab deruxtecan in non-breast solid tumors: Expanding indications, efficacy, and future directions.

Journal: Critical reviews in oncology/hematology

Published: September 16, 2025

Clinical Evidence for Microbiome-Based Strategies in Cancer Immunotherapy: A State-of-the-Art Review.

Clinical Evidence for Microbiome-Based Strategies in Cancer Immunotherapy: A State-of-the-Art Review.

Journal: Medicina (Kaunas, Lithuania)

Published: August 06, 2025

Showing 1-12 of 102

Last Updated: 09/26/2026